325:
506:
465:
38:
311:
544:
318:
304:
69:
161:
1645:
1637:
113:
Our goals are to improve medical genetics related articles, rate works about genetics disorders and create featured articles. The main scopes of the project are outlined below. If you want to discuss and create practical advice to help editors, please visit
234:
115:
1121:
354:
294:
273:
287:
136:
280:
202:
242:
182:
450:
186:
230:
430:
226:
925:
888:
826:
795:
440:
435:
425:
1623:
222:
857:
445:
213:
1601:
194:
675:
238:
190:
1125:
1000:
755:
715:
1691:
400:
198:
178:
549:
511:
470:
1653:
217:
632:
589:
1016:
261:
1184:
985:
965:
700:
45:
Welcome to this medicine task force. If you have any questions about articles or are generally seeking advice, you're encouraged to ask at the
975:
970:
960:
903:
898:
780:
740:
46:
980:
939:
908:
840:
809:
257:
1619:
871:
683:
574:
489:
1706:
766:
723:
693:
688:
660:
617:
773:
761:
733:
728:
640:
600:
567:
562:
555:
480:
650:
645:
610:
605:
595:
525:
655:
174:
142:
17:
1690:
The first "importance" parameter is the subject's importance to the overall field of medicine, according to the system outlined
1615:
252:
1090:
1071:
1022:
991:
947:
916:
848:
817:
1694:. The importance of a subject to the field of medical genetics should be listed with the "genetics-imp" parameter.
1043:
879:
1057:
1050:
1036:
122:
1064:
706:
1514:
786:
746:
129:
580:
533:
495:
464:
666:
623:
1207:
This article has not yet been classified into the categories above. Please help by classifying this article.
505:
1427:
357:
shows all rated MEDGENP articles. Help rate articles by using the template below on the article talk page.
1300:
1542:
348:
88:
1319:
1281:
1477:
1581:
1464:
1611:
1568:
1078:
1528:
1489:
1502:
324:
1576:
Lacks references. Could expand details on list of diseases suggested merge a possibility
135:
If you are interested in medicine or genetics and want to join, please list yourself in
1676:
310:
23:
268:
1700:
1116:
1364:
To improve content on genetic basis , evidence of therapy, epidemiology. counselling
37:
1452:
1440:
1338:
1383:
To improve content as well as make it easy to understand for non-technical people
1555:
1376:
1357:
1345:
To add evidence on clinical use of gene therapy as evidence from clinical trials
317:
355:
Knowledge (XXG):Version 1.0 Editorial Team/Medical genetics articles by quality
303:
68:
1414:
1173:
The article needs expansion, organization, and/or a neutral point of view.
160:
1288:
Really interested in this article/ would like to see this article expanded
1139:
1607:
Article alerts not yet available. Please allow some days for processing.
1389:
1644:
1636:
1422:
needs a few more references, fact checking, very close to A article
1589:
Lacks sections, references, links suggested merge a possibility
1183:
The article is in good shape. With a little care, it could be a
1163:
This article is in poor condition, and could use a lot of help.
1686:{{WPMED |class= |importance= |genetics=yes |genetics-imp= }}
159:
1250:
63:
128:
And the most important part of the project is to fulfill
1248:
If you have a job for the project, please list it here:
1682:. It can be inserted into an article's talkpage with:
1648:
1640:
1628:
103:
96:
1435:
bigger topic, no image, reference, few external links
408:
Medical genetics articles by quality and importance
1668:The template for marking an article as part of the
407:
141:Most of our articles are also within the scope of
1153:Please help turn this stub into a full article.
1326:To add cited information on genetic basis of RA
1201:
1191:
1177:
1167:
1157:
1147:
1563:no references! suggested merge a possibility
1197:This is a featured article! Congratulations!
8:
1672:is part of the WikiProject Medicine banner,
1398:First we should improve our main articles:
404:
1497:has section stubs more links are needed.
462:
49:, the centralized point for discussion,
439:
434:
429:
424:
187:Identifying reliable sources (medicine)
42:
503:
444:
7:
543:
541:
121:We rate and improve all articles of
18:Knowledge (XXG):WikiProject Medicine
449:
389:Medical genetics article assessment
351:recently featured on the main page!
1522:references copyed of weasel words
31:
1643:
1635:
1537:needs help with history, ethics
1214:The color codes are as follows:
542:
504:
463:
323:
316:
309:
302:
67:
36:
1585:
1572:
1559:
1546:
1533:
1518:
1506:
1493:
1481:
1468:
1456:
1444:
1431:
1418:
1265:
1258:
1253:
1:
43:
35:
1707:Medical genetics task force
1670:Medical genetics task force
398:Medical genetics task force
366:Articles for (peer) review!
179:WPMED Newsletter and signup
79:Medical genetics task force
1723:
1185:Featured Article candidate
183:Manual of style (medicine)
123:Genetic disorders category
86:
1515:Human genetic engineering
1397:
1393:General medical genetics
1392:
1142:
1105:
1097:
1085:
417:
412:
130:List of genetic disorders
1550:close to start class...
116:article advice talk page
1428:Anticipation (genetics)
24:Knowledge (XXG):MEDGENP
164:
1543:Mitochondrial disease
1307:To promote to A class
1143:Article Alert Status
401:assessment statistics
235:Patrol recent changes
218:resources for editors
163:
1409:Comments (optional)
1320:Rheumatoid Arthritis
1282:Behavioural Genetics
349:Huntington's Disease
341:News, announcements!
191:List of participants
169:WikiProject Medicine
143:WikiProject:Genetics
1478:Deletion (genetics)
334:News, announcements
1582:X-linked recessive
1465:Genetic counseling
1270:
1263:
1244:List of open tasks
1212:
368:
343:
243:Requested articles
165:
146:
137:participants' list
83:
47:Medicine talk page
1658:for other topics!
1610:Updated daily by
1593:
1592:
1569:X-linked dominant
1388:
1387:
1301:Tay–Sachs disease
1266:
1259:
1211:
1210:
1138:
1132:
1131:
1113:
1112:
364:
339:
331:
330:
152:
151:
85:
75:
59:
58:
22:(Redirected from
1714:
1681:
1675:
1647:
1639:
1624:Request feature?
1529:Medical genetics
1490:Genetic disorder
1390:
1251:
1239:
1233:
1229:
1225:
1221:
1217:
1140:
1119:
1102:
1093:
1087:WikiWork factors
547:
546:
545:
509:
508:
468:
467:
405:
393:
392:
327:
320:
313:
306:
269:
106:
99:
82:
71:
64:
40:
33:
32:
27:
1722:
1721:
1717:
1716:
1715:
1713:
1712:
1711:
1697:
1696:
1679:
1673:
1666:
1661:
1634:(Subscribe via
1605:
1598:
1503:Genetic testing
1246:
1235:
1231:
1227:
1223:
1219:
1215:
1137:
1115:
1100:
1091:
391:
383:
382:
369:
361:
360:
344:
336:
267:
266:
171:
110:
109:
102:
95:
91:
77:Welcome to the
76:
55:
29:
28:
21:
20:
12:
11:
5:
1720:
1718:
1710:
1709:
1699:
1698:
1688:
1687:
1665:
1664:Project notice
1662:
1656:Article Alerts
1630:Click to watch
1626:
1609:
1602:Article alerts
1599:
1597:
1596:Article alerts
1594:
1591:
1590:
1587:
1584:
1578:
1577:
1574:
1571:
1565:
1564:
1561:
1558:
1552:
1551:
1548:
1545:
1539:
1538:
1535:
1532:
1524:
1523:
1520:
1517:
1511:
1510:
1508:
1505:
1499:
1498:
1495:
1492:
1486:
1485:
1483:
1480:
1474:
1473:
1472:no references
1470:
1467:
1461:
1460:
1458:
1455:
1449:
1448:
1446:
1443:
1437:
1436:
1433:
1430:
1424:
1423:
1420:
1417:
1411:
1410:
1407:
1404:
1400:
1399:
1395:
1394:
1386:
1385:
1380:
1373:
1367:
1366:
1361:
1354:
1348:
1347:
1342:
1335:
1329:
1328:
1323:
1316:
1310:
1309:
1304:
1297:
1291:
1290:
1285:
1278:
1272:
1271:
1264:
1257:
1245:
1242:
1209:
1208:
1205:
1199:
1198:
1195:
1189:
1188:
1181:
1175:
1174:
1171:
1165:
1164:
1161:
1155:
1154:
1151:
1145:
1144:
1136:
1133:
1130:
1129:
1111:
1110:
1104:
1096:
1083:
1082:
1075:
1068:
1061:
1054:
1047:
1040:
1033:
1027:
1026:
1019:
1014:
1012:
1010:
1008:
1006:
1004:
996:
995:
988:
983:
978:
973:
968:
963:
958:
952:
951:
944:
942:
937:
935:
933:
931:
929:
921:
920:
913:
911:
906:
901:
896:
894:
892:
884:
883:
876:
874:
869:
867:
865:
863:
861:
853:
852:
845:
843:
838:
836:
834:
832:
830:
822:
821:
814:
812:
807:
805:
803:
801:
799:
791:
790:
783:
778:
776:
771:
769:
764:
759:
751:
750:
743:
738:
736:
731:
726:
721:
719:
711:
710:
703:
698:
696:
691:
686:
681:
679:
671:
670:
663:
658:
653:
648:
643:
638:
636:
628:
627:
620:
615:
613:
608:
603:
598:
593:
585:
584:
577:
572:
570:
565:
560:
558:
553:
538:
537:
530:
528:
523:
521:
519:
517:
515:
500:
499:
492:
487:
485:
483:
478:
476:
474:
459:
458:
453:
448:
443:
438:
433:
428:
422:
421:
416:
410:
409:
390:
387:
385:
380:
379:
377:
376:
374:Currently none
370:
363:
362:
359:
358:
352:
345:
338:
337:
335:
332:
329:
328:
321:
314:
307:
299:
298:
295:Article rating
291:
284:
277:
274:Article advice
264:
255:
251:
245:
241:
233:
220:
214:Article alerts
212:
206:
197:
193:
189:
185:
181:
177:
173:
167:
166:
158:
157:
155:
154:
150:
149:
148:
147:
111:
108:
107:
100:
92:
87:
84:
74:
72:
61:
57:
56:
41:
30:
15:
14:
13:
10:
9:
6:
4:
3:
2:
1719:
1708:
1705:
1704:
1702:
1695:
1693:
1685:
1684:
1683:
1678:
1671:
1663:
1660:
1659:
1657:
1650:
1646:
1642:
1638:
1633:
1632:
1631:
1625:
1621:
1617:
1613:
1608:
1604:
1603:
1595:
1588:
1583:
1580:
1579:
1575:
1570:
1567:
1566:
1562:
1557:
1554:
1553:
1549:
1544:
1541:
1540:
1536:
1531:
1530:
1526:
1525:
1521:
1516:
1513:
1512:
1509:
1504:
1501:
1500:
1496:
1491:
1488:
1487:
1484:
1479:
1476:
1475:
1471:
1466:
1463:
1462:
1459:
1454:
1451:
1450:
1447:
1442:
1439:
1438:
1434:
1429:
1426:
1425:
1421:
1416:
1413:
1412:
1408:
1405:
1402:
1401:
1396:
1391:
1384:
1381:
1379:
1378:
1374:
1372:
1371:Drsoumyadeepb
1369:
1368:
1365:
1362:
1360:
1359:
1355:
1353:
1352:Drsoumyadeepb
1350:
1349:
1346:
1343:
1341:
1340:
1336:
1334:
1333:Drsoumyadeepb
1331:
1330:
1327:
1324:
1322:
1321:
1317:
1315:
1314:Drsoumyadeepb
1312:
1311:
1308:
1305:
1303:
1302:
1298:
1296:
1293:
1292:
1289:
1286:
1284:
1283:
1279:
1277:
1274:
1273:
1269:
1262:
1256:
1252:
1249:
1243:
1241:
1238:
1206:
1204:
1203:needs opinion
1200:
1196:
1194:
1190:
1186:
1182:
1180:
1176:
1172:
1170:
1166:
1162:
1160:
1156:
1152:
1150:
1146:
1141:
1135:Main articles
1134:
1128:
1127:
1123:
1118:
1109:
1103:
1094:
1088:
1084:
1081:
1080:
1076:
1074:
1073:
1069:
1067:
1066:
1062:
1060:
1059:
1055:
1053:
1052:
1048:
1046:
1045:
1041:
1039:
1038:
1034:
1032:
1029:
1028:
1025:
1024:
1020:
1018:
1015:
1013:
1011:
1009:
1007:
1005:
1003:
1002:
998:
997:
994:
993:
989:
987:
984:
982:
979:
977:
974:
972:
969:
967:
964:
962:
959:
957:
954:
953:
950:
949:
945:
943:
941:
938:
936:
934:
932:
930:
928:
927:
923:
922:
919:
918:
914:
912:
910:
907:
905:
902:
900:
897:
895:
893:
891:
890:
886:
885:
882:
881:
877:
875:
873:
870:
868:
866:
864:
862:
860:
859:
855:
854:
851:
850:
846:
844:
842:
839:
837:
835:
833:
831:
829:
828:
824:
823:
820:
819:
815:
813:
811:
808:
806:
804:
802:
800:
798:
797:
793:
792:
789:
788:
784:
782:
779:
777:
775:
772:
770:
768:
765:
763:
760:
758:
757:
753:
752:
749:
748:
744:
742:
739:
737:
735:
732:
730:
727:
725:
722:
720:
718:
717:
713:
712:
709:
708:
704:
702:
699:
697:
695:
692:
690:
687:
685:
682:
680:
678:
677:
673:
672:
669:
668:
664:
662:
659:
657:
654:
652:
649:
647:
644:
642:
639:
637:
635:
634:
630:
629:
626:
625:
621:
619:
616:
614:
612:
609:
607:
604:
602:
599:
597:
594:
592:
591:
587:
586:
583:
582:
578:
576:
573:
571:
569:
566:
564:
561:
559:
557:
554:
552:
551:
540:
539:
536:
535:
531:
529:
527:
524:
522:
520:
518:
516:
514:
513:
507:
502:
501:
498:
497:
493:
491:
488:
486:
484:
482:
479:
477:
475:
473:
472:
466:
461:
460:
457:
454:
452:
447:
442:
437:
432:
427:
423:
420:
415:
411:
406:
403:
402:
399:
395:
394:
388:
386:
381:
375:
372:
371:
367:
356:
353:
350:
347:
346:
342:
333:
326:
322:
319:
315:
312:
308:
305:
301:
300:
297:
296:
292:
290:
289:
285:
283:
282:
278:
276:
275:
271:
270:
265:
263:
259:
254:
250:
246:
244:
240:
236:
232:
228:
224:
221:Articles for
219:
215:
211:
207:
204:
200:
196:
195:Popular pages
192:
188:
184:
180:
176:
170:
162:
156:
144:
140:
138:
133:
131:
126:
124:
119:
117:
105:
101:
98:
94:
93:
90:
80:
73:
70:
66:
65:
62:
54:
52:
48:
39:
34:
25:
19:
1689:
1669:
1667:
1655:
1652:
1629:
1627:
1606:
1600:
1527:
1453:Gene therapy
1441:Cytogenetics
1382:
1375:
1370:
1363:
1356:
1351:
1344:
1339:Gene Therapy
1337:
1332:
1325:
1318:
1313:
1306:
1299:
1294:
1287:
1280:
1275:
1267:
1260:
1254:
1247:
1236:
1213:
1202:
1192:
1178:
1168:
1158:
1148:
1114:
1107:
1099:
1086:
1077:
1070:
1063:
1056:
1049:
1042:
1035:
1030:
1021:
999:
990:
955:
946:
924:
915:
887:
878:
856:
847:
825:
816:
794:
785:
754:
745:
714:
705:
674:
665:
631:
622:
588:
579:
548:
532:
510:
494:
469:
455:
418:
413:
397:
396:
384:
378:
373:
365:
340:
293:
288:Participants
286:
279:
272:
256:Articles by
248:
247:
210:How to help:
209:
208:
175:Project Page
172:
168:
153:
134:
127:
120:
112:
78:
60:
50:
44:
1620:Report bug?
1556:Sex linkage
1377:Epigenetics
1358:Thalassemia
1276:Zzaffuto118
249:Categories:
1415:Aneuploidy
1001:Unassessed
419:Importance
281:Open Tasks
262:importance
239:sort stubs
199:Assessment
1612:AAlertBot
97:WP:MEDGEN
89:Shortcuts
51:thank you
1701:Category
1616:Discuss?
1403:Article
1193:featured
1126:category
1117:worklist
956:Assessed
926:Template
889:Redirect
827:Disambig
796:Category
231:orphaned
227:deletion
1547:B-class
1534:B-class
1519:B-class
1507:B-class
1494:B-class
1457:B-class
1445:B-class
1419:B-class
1406:Status
1268:Comment
1261:Article
1237:#FFFFFF
1232:#00CC00
1228:#77BBFF
1224:#FFFF66
1220:#FF9900
1216:#FF5555
1179:A-class
1169:B-class
858:Project
414:Quality
258:quality
253:Project
229:, and
223:cleanup
104:WP:WPMG
1295:Ebe123
1255:Editor
1234:, and
1677:WPMED
1654:Find
1586:start
1573:start
1560:start
1482:start
1469:start
1432:start
1159:start
1101:4,616
1079:1,235
1031:Total
992:1,234
676:Start
456:Total
16:<
1692:here
1651:) ·
1649:Atom
1149:stub
1108:4.48
1106:Ω =
1098:ω =
756:List
716:Stub
431:High
260:and
237:and
216:and
1641:RSS
1122:log
1072:699
1065:188
1058:227
986:698
981:188
976:227
917:105
747:135
707:434
701:319
667:284
661:195
624:152
618:106
451:???
441:Low
436:Mid
426:Top
203:Log
125:.
1703::
1680:}}
1674:{{
1622:/
1618:/
1614:—
1240:.
1230:,
1226:,
1222:,
1218:,
1187:.
1124:•
1120:•
1095:)
1051:90
1044:27
971:90
966:27
909:99
818:81
810:81
787:11
741:56
734:69
694:85
689:27
651:43
646:35
641:10
611:20
606:14
601:11
581:22
575:16
550:GA
512:FM
471:FA
446:NA
225:,
139:.
132:.
118:.
53:.
1092:?
1089:(
1037:4
1023:1
1017:1
961:4
948:1
940:1
904:3
899:3
880:4
872:4
849:1
841:1
781:4
774:3
767:2
762:2
729:9
724:1
684:3
656:1
633:C
596:1
590:B
568:4
563:1
556:1
534:1
526:1
496:3
490:2
481:1
205:)
201:(
145:.
81:!
26:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
